Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
Unbuzzd Wellness Inc., a 19.84%-owned licensee of Quantum BioPharma, appointed Richard Buzbuzian as CEO to lead the nationwide commercialization of the hangover remedy unbuzzd. The subsidiary plans to launch sales in South Florida and Texas, targeting a functional beverage market projected to reach $198 billion in 2026.
Key figures
- Market cagr
- 10.79%
- Royalty cap usd
- $250 million
- Royalty rate final
- 3%
- Market size 2026 usd
- $198 billion
- Royalty rate initial
- 7%
- Subsidiary ownership percent
- 19.84%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.